IPO: Yield10 Bioscience, Inc

IPO: Yield10 Bioscience, Inc

Global food security is a big concept for a small company. To achieve its lofty goals, Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yields. The company has an extensive track record of innovation based around optimizing the flow of carbon in living systems, and it is leveraging … Read more

Invitae And ArcherDX Join Forces To Expand Cancer Genetics And Precision Oncology

Invitae And ArcherDX Join Forces To Expand Cancer Genetics And Precision Oncology

Invitae (NYSE: NVTA), a leading genetics and synthetic biology company, and ArcherDX, a leading genomics analysis company innovating in precision oncology, today announced the companies have entered into an agreement to combine. The combined company aims to advance care for cancer patients by accelerating adoption of genetics . Integrating germline testing, tumor profiling and liquid biopsy … Read more

FDA Issues Breakthrough Device Designation To New Device For Detection of NTRK fusions

FDA Issues Breakthrough Device Designation To New Device For Detection of NTRK fusions

ArcherDX, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its next-generation sequencing (NGS) device under development as a companion diagnostic (CDx) to detect neurotrophic receptor tyrosine kinase (NTRK) gene fusions that lead to the formation and growth of cancer. ArcherDX’s NGS technology utilizes proprietary Anchored Multiplex PCR … Read more

KcKinsey’s Bio Revolution Study Targets $4 Trillion Impact

KcKinsey’s Bio Revolution Study Targets $4 Trillion Impact

Advances in biological sciences, accelerated by computing, automation, and artificial intelligence (AI), is fueling a new wave of innovation that will impact economies and societies that will surpass the industrial revolution. In fact, these new capabilities and applications are already improving our response to global challenges from climate change to pandemics. But these innovations come … Read more

What Is Synthetic Biology Manufacturing Innovation Institute (Synbio MII)?

What Is Synthetic Biology Manufacturing Innovation Institute (Synbio MII)?

Earlier this year, the U.S. Government (USG) announced it will launch a competition for its ninth Manufacturing Innovation Institute (MII) led by the Department of Defense (DoD). The technical focus area for this Institute will be Synthetic Biology. Funding will be commensurate with the other DoD MIIs with similar expectations for cost-share from non-Federal sources … Read more

U.S. National Biodefense Strategy And COVID-19

U.S. National Biodefense Strategy And COVID-19

The emergence and spread of the COVID-19, which was declared a Public Health Emergency in the United States on January 31, 2020, has catalyzed significant activity by Federal, state, and local governments; the healthcare community; residents across the United States; and people around the world. The National Biodefense Strategy is the nation’s plan for ensuring … Read more